Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SUBODH K BHUCHAR

Allopathic & Osteopathic Physicians Family Medicine

NPI
1629082417
CMS profile
210092
Location
SUGAR LAND, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$687.61

39 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $681.61 38
Education $6.00 1

By paying entity

PY2019 · entire year · sorted by reported total

Page 1 of 1; records 1–39 of 39 matching records. This page contains 39 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SUBODH K BHUCHAR

NPI 1629082417 · CMS profile ID 210092

Allopathic & Osteopathic Physicians / Family Medicine

SUGAR LAND, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–39 of 39 matching records. This page contains 39 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1629082417?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SUBODH K BHUCHAR, NPI 1629082417, CMS profile ID 210092. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–39 of 39 matching records. This page contains 39 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1629082417?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). SUBODH K BHUCHAR, NPI 1629082417, CMS profile ID 210092. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–39 of 39 matching records. This page contains 39 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1629082417?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
SUBODH K BHUCHAR, NPI 1629082417, CMS profile ID 210092, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–39 of 39 matching records. This page contains 39 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1629082417?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

39 matching records · $687.61 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 39 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–39 of 39.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $15.7112/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685273459 CMS
Lilly USA, LLC $11.0012/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658193281 CMS
SANOFI PASTEUR INC. $24.8912/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691623405 CMS
AstraZeneca Pharmaceuticals LP $16.5411/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685297725 CMS
Novo Nordisk Inc $16.5111/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703532207 CMS
PFIZER INC. $20.7011/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673720769 CMS
Lilly USA, LLC $11.6010/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658179887 CMS
Amarin Pharma Inc. $14.1510/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699238999 CMS
Novo Nordisk Inc $20.9110/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 675004387 CMS
Janssen Pharmaceuticals, Inc $20.1110/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658330479 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.3310/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700206685 CMS
AstraZeneca Pharmaceuticals LP $16.6909/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685013771 CMS
Lilly USA, LLC $11.1408/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658189981 CMS
SANOFI-AVENTIS U.S. LLC $20.1508/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694136285 CMS
Allergan Inc. $12.3808/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670122249 CMS
Janssen Pharmaceuticals, Inc $12.4407/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658330473 CMS
AstraZeneca Pharmaceuticals LP $14.0307/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685395751 CMS
PFIZER INC. $21.4707/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672368993 CMS
Amgen Inc. $24.0806/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663085881 CMS
SANOFI-AVENTIS U.S. LLC $15.6006/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694300503 CMS
Merck Sharp & Dohme Corporation $11.8105/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695468865 CMS
Novo Nordisk Inc $16.9805/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 669583141 CMS
Novo Nordisk Inc $16.3705/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 669583143 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.5704/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700206687 CMS
Novo Nordisk Inc $19.0804/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 669538029 CMS
Novo Nordisk Inc $18.9403/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 669482863 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.5503/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700206689 CMS
Merck Sharp & Dohme Corporation $10.9303/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695318887 CMS
AstraZeneca Pharmaceuticals LP $40.9303/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685338211 CMS
Cranial Technologies, Inc $11.4203/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697182441 CMS
AstraZeneca Pharmaceuticals LP $23.1902/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685210345 CMS
Novo Nordisk Inc $22.4902/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 668731967 CMS
Genentech USA, Inc. $21.6702/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681219103 CMS
AstraZeneca Pharmaceuticals LP $6.0002/11/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685767441 CMS
Novo Nordisk Inc $22.4902/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 668731965 CMS
Novo Nordisk Inc $17.7702/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 668731963 CMS
AstraZeneca Pharmaceuticals LP $20.0201/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685953223 CMS
Endo Pharmaceuticals Inc. $17.8201/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685075061 CMS
Novo Nordisk Inc $16.1501/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 668731961 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $687.61 39
PY2020 $1,479.37 97
PY2021 $1,325.84 71
PY2022 $1,349.84 72
PY2023 $1,008.09 60
PY2024 $1,319.47 66
PY2025 $1,138.61 56

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $464,693.66 97
PY2024 Principal investigator $270,025.76 55
PY2023 Principal investigator $54,587.21 12
PY2022 Principal investigator $87,839.75 24
PY2021 Principal investigator $247,965.53 21
PY2020 Principal investigator $26,693.61 27
PY2019 Principal investigator $57,601.69 7

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,080.00 12/31/2023 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS - HOUSTON
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) No dispute reported 06/30/2026 998414267
Principal investigator 1 Bausch Health US, LLC $10,100.00 12/08/2023 Non-covered Recipient Entity
Pioneer Research Solutions Inc.
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1055195995
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $68.20 10/18/2023 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1035801051
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $68.20 10/18/2023 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1035801137
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $68.20 10/18/2023 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1035801149
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $68.20 10/18/2023 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1035801161
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $68.20 10/18/2023 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1035801173
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $68.20 10/18/2023 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1035801185
Principal investigator 1 Bausch Health US, LLC $10,100.00 09/22/2023 Non-covered Recipient Entity
Pioneer Research Solutions Inc.
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1055195991
Principal investigator 1 AstraZeneca Pharmaceuticals LP $2,300.11 08/31/2023 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS, INC
A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler MDI Relative to Budesonide and Formoterol Fumarate MDI and Symbicort pMDI in Adult and Adolescent Participants with Inadequately Controlled Asthma No dispute reported 06/30/2026 991133577
Principal investigator 1 AstraZeneca Pharmaceuticals LP $30,197.90 03/10/2023 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS, INC
A Phase III Randomized Double-blind Placebo-controlled Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442 a Combination Product of Two Monoclonal Antibodies AZD8895 and AZD1061 for Post-exposure Prophylaxis of COVID-19 No dispute reported 06/30/2026 991132609
Principal investigator 1 ABBVIE INC. $400.00 02/09/2023 Non-covered Recipient Entity
PIONEER RESEARCH SOLUTIONS INC
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) No dispute reported 06/30/2026 998369037